..................... ..................... ..................... ......
The summary displayed below was created by an LLM named 'llama3-8b-8192':
Here is a summary of the tentative ruling in YAML format:

```yaml
Case Number: 23STCV00719
Plaintiff: People of the State of California
Defendants: CaremarkPCS Health, LLC ("CVS Caremark"), CVS Health Corp. ("CVS Health"), Express Scripts, Inc., and OptumRX, Inc.
Judge: David S. Cunningham III

Demurrer:
  - Manufacturer Defendants' Demurrer: Sustained with leave to amend
  - PBM Defendants' Demurrer: Overruled
  - CVS Health's Demurrer: Sustained with leave to amend

Claims:
  - UCL: Overruled
  - Unfair Competiton Law: Overruled
  - Unjust Enrichment: Sustained with leave to amend
  - Fraud: Overruled

Key Points:
  - The Court agrees with the People that the allegations show a civil conspiracy between the Manufacturer Defendants and PBM Defendants.
  - The Court finds that the PBM Defendants' demurrer should be overruled.
  - The Court sustains the CVS Health demurrer with leave to amend.
  - The Court grants the People leave to amend the complaint to include new statements under Civil Code section 1770(a)(13) and/or facts showing violations of a different underlying statute, common law, etc.

Dates and Times:
  - Date: 6/18/24
  - Time: 9:00 am

People-Names:
  - Thomas Moriarty

Company-Names:
  - CVS Caremark
  - CVS Health
  - Express Scripts
  - OptumRX

Places:
  - California

Dates:
  - 2014
  - 2017

Events:
  - Name Change: CVS Caremark Corp. to CVS Health
  - Announcement of PBM Services: CVS Health

Money:
  - List prices for insulin: artificially inflated
  - Rebates and discounts: not disclosed

Intentions:
  - To increase profits through price collusion and rebating

Facts:
  - PBM Defendants receive significant secret rebates from Manufacturer Defendants
  - Manufacturer Defendants artificially inflate list prices for insulin
  - PBM Defendants negotiate with Manufacturer Defendants to obtain discounted acquisition costs

Disputes:
  - Overpricing of insulin
  - Misrepresentation of rebates and discounts
  - Failure to disclose rebating practices

Acts:
  - Artificial inflation of list prices
  - Secret rebating practices
  - Failure to disclose rebating practices

Laws:
  - Unfair Competition Law (UCL)
  - Unjust Enrichment
  - Civil Code section 1770(a)(13)

Case Citations:
  - Serrano v. Priest (1971) 5 Cal.3d 584
  - Hahn v. Mirda (2007) 147 Cal.App.4th 740
  - Aubry v. Tri-City Hospital Dist. (1992) 2 Cal.4th 962
  - Klein v. Chevron U.S.A., Inc. (2012) 202 Cal.App.4th 1342
  - Durell v. Sharp Healthcare (2010) 183 Cal.App.4th 1350
  - Stern, Business and Professions Code Section 17200 Practice (The Rutter Group March 2023 Update)
  - City of Oakland v. Oakland Raiders (2022) 83 Cal.App.5th 458
  -
